Conference Coverage
Conference Coverage
Drastic weight loss prevents progression to type 2 diabetes, PREVIEW data suggest
SAN FRANCISCO – In patients with prediabetes, weight loss of 8% or more over 2 months reduced conversion to diabetes over 3 years.
Conference Coverage
Four-drug combo bests triplet in newly diagnosed myeloma
CHICAGO – Results with daratumumab plus bortezomib, thalidomide, and dexamethasone are the “best ever reported in the setting of stem cell...
Conference Coverage
Pregnancy deemed safe in BRCA-mutated breast cancer survivors
Pregnancy did not affect disease-free or overall survival, and complications were similar to the general population.
Conference Coverage
Mutant huntingtin and neurofilament light are potential biomarkers in Huntington’s disease
PHILADELPHIA – The biomarkers successfully distinguish between healthy controls, patients with premanifest disease,...
Conference Coverage
Pivotal trial shows HFrEF benefits from baroreceptor stimulation
SAN FRANCISCO – Baroreflex activation therapy showed safety and 6-month efficacy in its FDA-approved pivotal trial.
Conference Coverage
Updated systematic review of aspirin primary prevention shows benefits, risks
Conference Coverage
Estimated prevalence of OSA in the Americas stands at 170 million
The United States has the greatest burden of OSA in the Americas, with an estimated 54 million cases.
Conference Coverage
How to reverse type 2 diabetes with a crash diet: the DiRECT approach
SAN FRANCISCO – A few months of a medically supervised liquid diet; durable remission at 2 years.
Conference Coverage
Balancing privacy, protection in at-risk MS patients
SEATTLE – Keep HIPAA, state laws, and professional guidelines in mind as you consider confidentiality’s limits, an attorney and neuroethics fellow...
Conference Coverage
Vitamin D did not reduce progression to type 2 diabetes in D2d trial
SAN FRANCISCO – Vitamin D supplementation failed to significantly reduce the risk of progression from prediabetes to...